📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-26 21:27
0 analysed today
0
Today
133,620
All-time analysed
40,132
Positive
6,284
Negative
79,384
Neutral
7,752
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
12 announcements match the current filters (relevance ≥ 5).
Punjab Chemicals Gets Relief in ₹44.96 Cr IGST Refund Litigation from Punjab & Haryana HC
Punjab Chemicals & Crop Protection Limited announced that the Punjab and Haryana High Court has disposed of its writ petition, providing relief against an IGST refund demand of approximately ₹44.96 crore along with interest and penalty. The dispute originated from a Show Cause Notice issued by GST authorities under Rule 96(10) of the CGST Rules. The High Court disposed of the matter following the Bombay High Court ruling in the Hikal Ltd. case. The removal of this potential liability represents a significant relief, as the ₹44.96 crore demand equals ~69% of the company's TTM net profit (₹65 crore).
Confidence: HIGH
What changedThe Punjab and Haryana High Court has disposed of the company's writ petition favorably, quashing/resolving the ₹44.96 crore IGST refund demand proceedings.
Why it mattersEliminates a substantial contingent tax liability of ₹44.96 crore, removing a material overhang on the company's balance sheet and cash flows.
Relief in IGST demand: ₹44.96 croreDemand vs TTM PAT (₹65 cr): ~69.2%Demand vs Net worth (₹443 cr): ~10.1%High Court Order Date: August 14, 2026
📅 Short termPositive sentiment driver as a large legal overhang is cleared without financial outflow or penalties.
📈 Long termStrengthens financial clarity and removes potential balance sheet strain from tax litigations under GST Rule 96(10).
⚠ Risk flags
- Departmental appeals or review petitions by the tax authority cannot be entirely ruled out until finality is reached
Key Highlights
High Court order dated August 14, 2026 provides relief against IGST recovery demand of ₹44.96 crore
Demand equaled ~69.2% of TTM PAT (₹65 crore) and ~10.1% of net worth (₹443 crore)
Writ petition (CWP-16072-2023) disposed in terms of Bombay HC judgment in Hikal Ltd. v. Union of India
No liability towards the ₹44.96 crore demand is presently expected to crystallise against the company
Company is taking consequential steps with GST authorities to remove the demand from records
👀 What to Watch
Track subsequent filings confirming the formal removal and updating of the ₹44.96 crore demand from GST records by tax authorities.
₹100 Cr Capex and ₹3 Dividend Announced at Punjab Chemicals 50th AGM
Punjab Chemicals reported a 14% revenue growth to ₹1030 Cr for FY26, with PAT rising to ₹64 Cr. The company has earmarked ₹100 Cr for two new multi-purpose manufacturing blocks and debottlenecking to support its growth strategy. Shareholders approved a final dividend of ₹3 per share (30%). Management highlighted a strong pipeline of 25 R&D products and three new exclusive MoUs with global customers, aiming to increase the revenue share of new products to 18-20% within two years.
Confidence: HIGH
What changedThe company has formalized its FY26 performance results and committed to a significant ₹100 Cr capacity expansion alongside a doubling of R&D expenditure.
Why it mattersThe expansion and focus on high-value CRAMS (60-70% of revenue) are critical to offset pricing pressures from Chinese manufacturers and improve overall margins from the current 11.5%.
Planned Capex: ₹100 CrCapex vs Net Worth: 22.57%FY26 Revenue: ₹1030 CrDividend per share: ₹3Agrochemical Capacity Utilization: 78%R&D Pipeline: 25 products
📅 Short termThe stock may see positive sentiment following the dividend approval and the clear roadmap for capacity expansion provided during the AGM.
📈 Long termThe structural shift toward higher-value offerings and increased R&D spending could re-rate the business if the 37% expected growth rate is achieved through the new manufacturing blocks.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- High client concentration with top 3 customers exceeding 50% of sales
- Pricing pressure from Chinese oversupply in legacy molecules
- Monsoon dependency for domestic agrochemical demand
Key Highlights
₹100 Cr investment planned for two new manufacturing blocks and capacity debottlenecking
₹3 per equity share (30%) final dividend declared for the financial year 2025-26
3 exclusive MoUs signed with global customers for high-value agrochemicals and intermediates
25 products currently in the R&D pipeline at various stages of development and piloting
New products contributed 15-16% to FY26 revenues, with a target to reach 18-20% by FY28
👀 What to Watch
Watch for the execution timeline of the ₹100 Cr capex and the commercialization of the three exclusive MoUs over the next 12-18 months to validate growth guidance.
Q1 FY27 Revenue up 9% to ₹347 Cr; ₹100 Cr Capex Planned for Capacity Expansion
Punjab Chemicals (PCCPL) reported a steady Q1 FY27 with revenue growing 8.7% YoY to ₹347.2 Cr, primarily driven by export recovery and a 40% surge in new product sales. EBITDA margins expanded by 100 bps to 11.8%, resulting in an 18.8% YoY growth in operating profit to ₹40.8 Cr. The company has formally earmarked ₹100 Cr for capex to establish two multi-purpose plants and is actively scouting for a new manufacturing site to support its 25+ product R&D pipeline. Strategic progress was noted in the CRAMS segment, with commercial lots supplied for 2 out of 3 global MoU products.
Confidence: HIGH
What changedThe company has moved from a period of flat growth in FY25 to a growth trajectory in Q1 FY27, backed by a concrete ₹100 Cr expansion plan and successful commercial trials for global partners.
Why it mattersThe shift toward high-value intermediates and CRAMS (60-70% of revenue) is critical for PCCPL to insulate itself from the commodity-driven pricing volatility of the generic agrochemical market.
Q1 FY27 Revenue: ₹347.2 CrEBITDA Margin: 11.8%Planned Capex: ₹100 CrCapex vs Net Worth: ~22.6%New Product Revenue Growth: 40% YoY
📅 Short termThe stock may see positive sentiment due to the margin expansion and the announcement of a sizeable capex plan relative to its net worth.
📈 Long termThe structural focus on CDMO/CRAMS and doubling R&D spend over two years suggests a transition toward a higher-margin, specialized chemical player, though client concentration remains a key monitorable.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- High client concentration (top 3 customers > 50% sales)
- Aggressive pricing from Chinese manufacturers
- Monsoon dependency for domestic segments
Key Highlights
Revenue grew 8.7% YoY to ₹347.2 Cr, with new products contributing 14% of total sales.
EBITDA increased 18.8% YoY to ₹40.8 Cr, supported by a 355 bps improvement in gross margins to 36.6%.
Planned capex of ₹100 Cr for two multi-purpose plants, representing approximately 22.6% of current Net Worth.
R&D pipeline currently holds over 25 products at various stages of development and piloting.
Export sales grew to ₹190 Cr in Q1 FY27 compared to ₹196 Cr in the previous year (slight dip but recovery from recent quarters).
👀 What to Watch
Monitor the execution timeline of the ₹100 Cr capex and the volume ramp-up of the MoU products starting Q4 FY27. Investors should also track the company's ability to maintain margins amidst ongoing pricing pressure from Chinese agrochemical exports.
Punjab Chemicals Q1 PAT Grows 10% to ₹22.15 Cr; Director Avtar Singh Resigns
Punjab Chemicals reported a steady Q1 FY27 with revenue from operations growing 8.7% YoY to ₹346.44 cr. Net profit increased by 10.3% YoY to ₹22.15 cr, reflecting resilience in a challenging agrochemical market. The company saw a significant sequential recovery from Q4 FY26, where revenue was ₹207.13 cr. Additionally, Non-Executive Director Mr. Avtar Singh resigned effective July 31, 2026, citing personal commitments.
Confidence: HIGH
What changedPunjab Chemicals reported its Q1 FY27 financial performance and announced the resignation of a Non-Executive Director.
Why it mattersThe results indicate a strong start to the fiscal year with YoY growth in both top and bottom lines, suggesting the company is navigating industry-wide headwinds effectively. The director's resignation appears routine and unlikely to impact operations.
Revenue (Q1 FY27): ₹346.44 crNet Profit (Q1 FY27): ₹22.15 crYoY Revenue Growth: 8.7%Q1 Revenue vs TTM Revenue: 33.6%EPS (Q1 FY27): ₹18.07
📅 Short termThe stock may react positively to the YoY growth in profitability and the sharp sequential recovery in revenue compared to the previous quarter.
📈 Long termLong-term value depends on the successful execution of the CRAMS-led growth strategy and reducing high client concentration (top 3 clients > 50% sales).
⚠ Risk flags
- High client concentration risk
- Aggressive pricing from Chinese manufacturers
- Monsoon dependency for domestic demand
Key Highlights
Revenue from operations increased 8.7% YoY to ₹346.44 cr from ₹318.59 cr.
Net profit for the quarter rose 10.3% YoY to ₹22.15 cr compared to ₹20.08 cr.
Earnings Per Share (EPS) improved to ₹18.07 from ₹16.38 in the year-ago period.
Total expenses for the quarter stood at ₹316.98 cr, with material costs accounting for ₹199.85 cr.
Finance costs remained stable at ₹4.11 cr compared to ₹3.95 cr in Q1 FY26.
👀 What to Watch
Monitor the company's ability to maintain margins in the CRAMS segment (60-70% of revenue) amidst continued pricing pressure from Chinese manufacturers. Watch for the commissioning of new blocks and product launches scheduled for FY26-27.
Punjab Chemicals Q1 PAT Rises 10.3% YoY to ₹22.15 Cr; Revenue Grows 8.7%
Punjab Chemicals & Crop Protection reported a steady Q1 FY27 with revenue from operations reaching ₹346.44 Cr, an 8.7% increase over the ₹318.59 Cr reported in the same quarter last year. Net profit for the quarter stood at ₹22.15 Cr, up 10.3% YoY from ₹20.08 Cr. Sequentially, the company saw a massive 67.2% jump in revenue compared to Q4 FY26 (₹207.13 Cr), reflecting the seasonal nature of the agrochemical business. Additionally, Mr. Avtar Singh resigned as a Non-Executive Director effective July 31, 2026.
Confidence: HIGH
What changedThe company reported its first-quarter results for FY27 showing growth in both top and bottom lines, alongside a change in the board composition due to a director's resignation.
Why it mattersThe results demonstrate resilience in the company's CRAMS-focused model (60-70% of revenue) despite a challenging global environment for agrochemicals characterized by pricing volatility.
Revenue (Q1 FY27): ₹346.44 CrPAT (Q1 FY27): ₹22.15 CrYoY Revenue Growth: 8.7%QoQ Revenue Growth: 67.2%EPS (Q1 FY27): ₹18.07Revenue vs TTM Revenue: ~33.6%
📅 Short termThe stock may see positive sentiment due to the strong sequential recovery and year-on-year growth in a sector that has been struggling with inventory destocking.
📈 Long termThe long-term outlook depends on the company's ability to execute its 37% growth target and leverage its R&D pipeline to offset pricing pressures in generic segments.
⚠ Risk flags
- High client concentration (top 3 customers > 50% sales)
- Aggressive pricing from Chinese manufacturers
- Monsoon dependency for domestic demand
Key Highlights
Revenue from operations grew 8.7% YoY to ₹346.44 Cr from ₹318.59 Cr.
Net profit increased 10.3% YoY to ₹22.15 Cr, with EPS rising to ₹18.07 from ₹16.38.
Sequential revenue growth was 67.2% compared to the March 2026 quarter (₹207.13 Cr).
Profit before tax (PBT) stood at ₹30.14 Cr, representing a margin of 8.7% for the quarter.
Cost of materials consumed remained the largest expense at ₹199.85 Cr, up from ₹174.28 Cr YoY.
👀 What to Watch
Investors should monitor the sustainability of these margins given the industry-wide pressure from Chinese oversupply and track the progress of the 'new blocks' scheduled for commissioning in FY26.
Punjab Chemicals FY26 PAT Jumps 64% to ₹64 Cr; Revenue Crosses ₹1,000 Cr Milestone
Punjab Chemicals & Crop Protection Limited (PCCPL) delivered a strong performance for FY26, with annual revenue growing 14.4% YoY to reach ₹1,029.8 crore. Profit After Tax (PAT) surged by 64.3% to ₹64 crore, supported by a significant improvement in PAT margins from 4.3% to 6.2%. The company is aggressively expanding its portfolio, with new products contributing 14% to total revenue and three new export MOUs signed for FY27. A planned capex of ₹60 crore for new manufacturing blocks and active scouting for a new site indicate a robust growth outlook.
Key Highlights
Annual revenue surpassed the ₹1,000 crore mark, growing 14.4% YoY to ₹1,029.8 crore.
Full-year PAT increased by 64.3% to ₹64 crore, while Q4 FY26 PAT grew 55.8% YoY to ₹11 crore.
EBITDA for FY26 rose 19.1% to ₹118.1 crore, driven by operational efficiencies and a refined product mix.
New products contributed 14% to FY26 revenue, showing a growth of 16% on a YoY basis.
Earmarked ₹60 crore capex for two multi-purpose plants and capacity debottlenecking over the next 6 quarters.
👀 What to Watch
Investors should take note of the significant margin expansion and the successful scaling of the CDMO and new product segments. The stock remains a watch for execution on the ₹60 crore capex and the commercialization of the three new export-oriented MOUs in FY27.
Punjab Chemicals FY26 Net Profit Surges 54% to ₹61.4 Crore; Declares ₹3 Dividend
Punjab Chemicals & Crop Protection Limited reported a strong performance for the fiscal year ended March 31, 2026, with annual revenue crossing the ₹1,000 crore milestone. The company's standalone net profit for FY26 jumped 54.5% to ₹61.4 crore compared to ₹39.8 crore in the previous fiscal. The Board has recommended a dividend of 30% (₹3 per share). Additionally, the company announced the appointment of new internal, cost, and tax auditors for FY 2026-27.
Key Highlights
Annual Revenue from operations grew 14.1% YoY to ₹1,02,540 Lakh (₹1,025.4 Cr).
Full-year Standalone Net Profit increased by 54.5% to ₹6,143 Lakh (₹61.4 Cr).
Board recommended a dividend of ₹3 per equity share (30% on face value of ₹10).
Q4 FY26 Net Profit rose 33.8% YoY to ₹998 Lakh compared to ₹746 Lakh in Q4 FY25.
Company appointed M/s S M A M & Co as Internal Auditors and M/s Khushwinder Kumar & Co as Cost Auditors for FY 2026-27.
👀 What to Watch
The significant growth in annual profitability and the crossing of the ₹1,000 crore revenue mark are strong positive indicators. Investors may consider holding for long-term growth in the agrochemical space, given the healthy dividend payout and unmodified audit opinion.
Punjab Chemicals Reports 54% FY26 Profit Growth; Recommends Rs. 3 Dividend
Punjab Chemicals & Crop Protection Limited reported a strong performance for the financial year ended March 31, 2026, with annual revenue growing 14% to Rs. 1,025.4 crore. Net profit for the year surged by approximately 54% to Rs. 61.43 crore, up from Rs. 39.77 crore in the previous fiscal. The Board has recommended a dividend of 30% (Rs. 3 per share), reflecting healthy cash flow and operational growth. The company also reported a significant improvement in annual EPS, rising to Rs. 50.11 from Rs. 32.44.
Key Highlights
Annual revenue from operations increased to Rs. 1,02,540 lakh in FY26 from Rs. 89,838 lakh in FY25.
Net profit for the full year FY26 rose to Rs. 6,143 lakh, a 54.4% increase year-on-year.
Board recommended a dividend of Rs. 3 per equity share (30% of face value) for FY26.
Full-year Earnings Per Share (EPS) improved significantly to Rs. 50.11 from Rs. 32.44.
Q4 FY26 standalone net profit stood at Rs. 998 lakh on a revenue of Rs. 20,713 lakh.
👀 What to Watch
Investors should take note of the robust bottom-line growth and the consistent dividend payout as signs of strengthening fundamentals. The stock remains attractive for those looking at growth in the specialty chemicals and crop protection space, though margin sustainability should be monitored.
Punjab Chemicals FY26 Net Profit Surges 54% to ₹61.4 Cr; Declares ₹3 Dividend
Punjab Chemicals reported a robust performance for the fiscal year ended March 31, 2026, with annual revenue crossing the ₹1,000 crore milestone to reach ₹1,025.4 crore. Net profit for the full year jumped significantly by 54.5% to ₹61.4 crore, up from ₹39.8 crore in the previous fiscal. The Board has recommended a dividend of ₹3 per share (30% of face value), reflecting strong cash flow. While annual growth was strong, the Q4 profit of ₹9.98 crore showed a sequential decline compared to Q3 FY26, though it remained higher than Q4 FY25.
Key Highlights
Annual Revenue from operations grew 14.1% YoY to ₹1,02,540 Lakh.
Full-year Net Profit increased by 54.5% to ₹6,143 Lakh from ₹3,977 Lakh in FY25.
Earnings Per Share (EPS) for the year rose to ₹50.11 from ₹32.44.
Board recommended a dividend of 30% (₹3 per equity share of ₹10 each).
Total Comprehensive Income for FY26 stood at ₹6,223 Lakh versus ₹3,953 Lakh in the previous year.
👀 What to Watch
Investors should take note of the significant improvement in annual profitability and the company's ability to scale revenue beyond ₹1,000 crore. The stock remains attractive for long-term holders given the 54% profit growth and consistent dividend payout.
Punjab Chemicals Q3 FY26 PAT Jumps 127.7% YoY to ₹13.8 Cr; Revenue Up 15.3%
Punjab Chemicals reported a strong Q3 FY26 performance with revenue growing 15.3% YoY to ₹246.6 Cr, driven by improved domestic and export demand. Profitability saw a significant boost as PAT surged 127.7% YoY to ₹13.8 Cr, while EBITDA margins expanded to 12.0% from 9.0% in the previous year. The company is aggressively expanding its product pipeline with three new MOUs signed for exports and ₹60 Cr capex earmarked for capacity expansion. For the 9M FY26 period, revenue reached ₹821.2 Cr with a PAT of ₹53.0 Cr, representing a 66.2% YoY growth.
Key Highlights
Q3 FY26 Revenue grew 15.3% YoY to ₹246.6 Cr, while 9M FY26 Revenue rose 17.6% to ₹821.2 Cr.
EBITDA for the quarter increased 53.5% YoY to ₹29.6 Cr, with margins improving to 12.0%.
PAT witnessed a massive 127.7% YoY growth to ₹13.8 Cr in Q3 FY26.
Signed 3 MOUs for export-oriented products and earmarked ₹60 Cr for new manufacturing blocks.
Commercial production trials for 4 new products are underway for Q4 FY26.
👀 What to Watch
Investors should note the significant margin expansion and robust PAT growth as a sign of operational efficiency and better product mix. The company's focus on CDMO and new product commercialization provides a strong visibility for growth over the next 2-3 years.
Punjab Chemicals Q3 PAT Surges 110% YoY to ₹13.99 Cr; Revenue Up 15%
Punjab Chemicals reported a strong year-on-year performance for Q3 FY26, with standalone revenue growing 15% to ₹245.9 crore compared to ₹213.6 crore in the previous year. Net profit (PAT) saw a significant jump of 110% YoY to ₹13.99 crore, although it declined sequentially from ₹17.39 crore in Q2 FY26. The company recognized an exceptional expense of ₹2.08 crore due to the implementation of New Labour Codes. For the nine-month period, the company demonstrated robust growth with PAT increasing by 59% to ₹51.45 crore.
Key Highlights
Revenue from operations grew 15.1% YoY to ₹245.92 crore in Q3 FY26.
Net Profit (PAT) surged 110% YoY to ₹13.99 crore, with EPS rising to ₹11.41 from ₹5.42.
Nine-month (9M FY26) PAT stands at ₹51.45 crore, a 59.2% increase over the previous year.
Exceptional item of ₹2.08 crore recorded towards provision for employee benefits under New Labour Codes.
Interest income of ₹1.86 crore accrued on income tax refunds during the quarter following favorable ITAT orders.
👀 What to Watch
Investors should note the strong year-on-year recovery and margin expansion in the performance chemicals segment. While there is a slight sequential dip, the overall nine-month growth trajectory remains robust, making it a positive hold for long-term investors.
Punjab Chemicals Appoints Devender Gupta as CFO Effective December 16, 2025
Punjab Chemicals and Crop Protection Limited has appointed Mr. Devender Gupta as the new Chief Financial Officer, effective December 16, 2025. He fills the vacancy created by the resignation of the previous CFO, Mr. Vikash Khanna. Mr. Gupta is a Chartered Accountant with over 28 years of experience in financial management, including fund raising and M&A. His previous experience includes senior roles at Panacea Biotec and Jubilant Lifesciences, bringing significant industry expertise to the company.
Key Highlights
Mr. Devender Gupta appointed as CFO effective December 16, 2025
Brings over 28 years of experience in financial management, fund raising, and M&A
Previously worked with reputable firms like Panacea Biotec and Jubilant Lifesciences
Appointment fills the vacancy caused by the resignation of Mr. Vikash Khanna
Expertise includes ERP implementation, strategic planning, and investor relations
👀 What to Watch
Investors should monitor the transition and look for any shifts in financial strategy or capital allocation under the new leadership. His extensive experience in fund raising and M&A could signal future growth or restructuring initiatives.
